Improving the Detection of p53 Mutations in Breast Cancer by Use of the FASAY, a Functional Assay
- 31 August 2000
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 2 (3), 139-144
- https://doi.org/10.1016/s1525-1578(10)60629-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prognostic significance ofp53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assayInternational Journal of Cancer, 1999
- Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysisBritish Journal of Cancer, 1999
- p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancerInternational Journal of Cancer, 1997
- Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like familyOncogene, 1997
- Inhibition of PCR Amplification by a Point Mutation Downstream of a PrimerBioTechniques, 1997
- DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies.1996
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsNature Medicine, 1996
- COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspectiveCarcinogenesis: Integrative Cancer Research, 1996
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- A simple p53 functional assay for screening cell lines, blood, and tumors.Proceedings of the National Academy of Sciences, 1995